MXPA04012732A - Plataforma para formulaciones transdermicas (pft). - Google Patents

Plataforma para formulaciones transdermicas (pft).

Info

Publication number
MXPA04012732A
MXPA04012732A MXPA04012732A MXPA04012732A MXPA04012732A MX PA04012732 A MXPA04012732 A MX PA04012732A MX PA04012732 A MXPA04012732 A MX PA04012732A MX PA04012732 A MXPA04012732 A MX PA04012732A MX PA04012732 A MXPA04012732 A MX PA04012732A
Authority
MX
Mexico
Prior art keywords
platform
ptf
transdermal formulations
therapeutically active
transdermal
Prior art date
Application number
MXPA04012732A
Other languages
English (en)
Spanish (es)
Inventor
Simha Landschaft Yuval
Original Assignee
Holden Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Holden Dev Ltd filed Critical Holden Dev Ltd
Publication of MXPA04012732A publication Critical patent/MXPA04012732A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA04012732A 2002-06-27 2003-06-21 Plataforma para formulaciones transdermicas (pft). MXPA04012732A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10228680A DE10228680A1 (de) 2002-06-27 2002-06-27 Grundlage für transdermale Formulierungen (PTF)
PCT/IB2003/003467 WO2004002444A2 (en) 2002-06-27 2003-06-21 A platform for transdermal formulations (ptf)

Publications (1)

Publication Number Publication Date
MXPA04012732A true MXPA04012732A (es) 2005-11-17

Family

ID=29761469

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04012732A MXPA04012732A (es) 2002-06-27 2003-06-21 Plataforma para formulaciones transdermicas (pft).

Country Status (14)

Country Link
US (1) US20050118241A1 (enExample)
EP (1) EP1515706A2 (enExample)
JP (1) JP2005535635A (enExample)
KR (1) KR20050027995A (enExample)
CN (1) CN1665492A (enExample)
AR (1) AR040287A1 (enExample)
AU (1) AU2003252459A1 (enExample)
CA (1) CA2490022A1 (enExample)
DE (1) DE10228680A1 (enExample)
MX (1) MXPA04012732A (enExample)
MY (1) MY157852A (enExample)
TW (1) TW200500093A (enExample)
WO (1) WO2004002444A2 (enExample)
ZA (1) ZA200500710B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033998B2 (en) * 2003-04-11 2006-04-25 All Natural Fmg, Inc. Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
WO2005094210A2 (en) * 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
US10042980B2 (en) 2005-11-17 2018-08-07 Gearbox Llc Providing assistance related to health
US10296720B2 (en) 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US20110145009A1 (en) * 2005-11-30 2011-06-16 Jung Edward K Y Methods and systems related to transmission of nutraceutical associatd information
WO2010132562A2 (en) * 2009-05-12 2010-11-18 Ohio University Transdermal delivery of metformin
CA2763040C (en) * 2009-06-05 2018-05-01 Joan M. Caron Methods and compositions for the treatment of cancer
MX361155B (es) * 2012-07-30 2018-11-28 Matinas Biopharma Nanotechnologies Inc Cocleatos hechos con fosfatidilserina de soja.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4878892A (en) * 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
FR2616333A1 (fr) * 1987-06-12 1988-12-16 Cird Procede d'ionophorese pour administrer une substance dissoute ou partiellement dissoute, par voie percutanee ou perungueale et dispositif correspondant
JPS63316737A (ja) * 1987-06-19 1988-12-26 Toyo Jozo Co Ltd 経鼻投与用医薬組成物
IT1223343B (it) * 1987-11-03 1990-09-19 Also Lab Sas Formulazioni farmaceutiche per somministrazione transdermica
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
EP0429842B1 (en) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
US5073539A (en) * 1990-01-22 1991-12-17 Ciba-Geigy Corporation Transdermal administration of zwitterionic drugs
DE69216836T2 (de) * 1991-07-26 1997-06-12 Smithkline Beecham Corp W/o mikroemulsionen
FR2687321B1 (fr) * 1992-02-14 1999-04-16 Elf Aquitaine Dispositif d'ionophorese pour l'administration transcutanee d'une quantite totale donnee d'un principe actif a un sujet.
EP0739644A4 (en) * 1994-09-30 1998-12-09 Advance Kk INTERFACE FOR A TRANSDERMAL IONTOPHORETIC DEVICE AND CORRECT MEDICINE
US5707641A (en) * 1994-10-13 1998-01-13 Pharmaderm Research & Development Ltd. Formulations comprising therapeutically-active proteins or polypeptides
US5759445A (en) * 1995-05-24 1998-06-02 Matsushita Electric Industrial Co., Ltd. Lipid-dispersed solution and process for producing the same
US6183758B1 (en) * 1998-01-29 2001-02-06 Highland Laboratories, Inc. Phytochemicals, nutrients & medication absorption &/or treatment
EP1094781B1 (en) * 1998-07-07 2008-07-02 Transdermal Technologies Inc. Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof
BR0010354A (pt) * 1999-05-07 2002-03-05 Pharmasol Gmbh Partìculas de lipìdeo à base em misturas de lipìdeos lìquidos e sólidos e método para a sua produção
US6309663B1 (en) * 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents

Also Published As

Publication number Publication date
KR20050027995A (ko) 2005-03-21
EP1515706A2 (en) 2005-03-23
TW200500093A (en) 2005-01-01
AU2003252459A1 (en) 2004-01-19
WO2004002444A3 (en) 2004-03-11
CN1665492A (zh) 2005-09-07
MY157852A (en) 2016-07-29
AR040287A1 (es) 2005-03-23
US20050118241A1 (en) 2005-06-02
WO2004002444A2 (en) 2004-01-08
CA2490022A1 (en) 2004-01-08
JP2005535635A (ja) 2005-11-24
ZA200500710B (en) 2005-09-05
DE10228680A1 (de) 2004-01-22

Similar Documents

Publication Publication Date Title
MY141815A (en) Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer
MXPA04004842A (es) Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1.
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
AP1954A (en) Controlled release compositions comprising nimesulide.
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
DK1299348T3 (da) Forbindelser og sammensætninger til levering af aktive midler
AU2274201A (en) Compounds and compositions for delivering active agents
TR200103493T2 (tr) Metaloproteaz önleyicileri
GB2388778B (en) Method and composition for combatting pesticide resistance
NZ524767A (en) Composition for the transdermal delivery of fentanyl
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
SE0102843D0 (sv) Stabilized oral pharmaceutical composition containing lodide and lodate and method
AU2084801A (en) Antiviral medication
WO2004058721A3 (en) Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity
MXPA04012732A (es) Plataforma para formulaciones transdermicas (pft).
TW200507838A (en) Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator
TR200200683T2 (tr) Oral kontrollü salıverme formülasyonları.
SE9800905D0 (sv) New therapy in glomerulonephritis
AU2002241270A1 (en) Compositions for delivering biologically active drug and method of using the same
AU2003235931A1 (en) Vintoperol-containing medicinal composition for transdermal administration
AU2002236587A1 (en) Compositions for adhesion prevention
AU6629000A (en) Novel hypoxanthine and thiohypoxanthine compounds
MXPA04006269A (es) Composicion farmaceutica que comprende un inhibidor de alfa-glucosidasa y acido 4-oxobutanoico y uso de la misma para tratamiento de diabetes.
WO2004056353A3 (en) Device and method for delivering mmp inhibitors
NZ521515A (en) Composition comprising paracetamol and niflumic acid

Legal Events

Date Code Title Description
FA Abandonment or withdrawal